Associate, Life Sciences

Company Overview

General Atlantic is a leading global investor with more than four and a half decades of experience providing capital and strategic support for over 885 companies throughout its history. Established in 1980, the firm manages approximately $126 billion in assets under management (as of March 31 2026) and employs more than 900 professionals in 20 countries across five regions. It operates across Growth Equity, Infrastructure, and Strategic Solutions.

Life Sciences Practice

The GA Life Sciences practice provides capital and strategic support for development‑stage biopharma companies, focusing on novel therapies that deliver substantial patient benefit and can redefine standards of care. The team employs thematic investing, scaling capital through clinical development and commercialization, and partners with management teams to generate value. Notable investments include Akero Therapeutics (acquired by Novo Nordisk), Karuna Therapeutics (acquired by BMS), Cincor Pharma (acquired by AstraZeneca), and Centessa Pharmaceuticals (potential acquisition by Eli Lilly).

Position Summary

General Atlantic is seeking a Life Sciences investor to join its New York‑based investment team. The role provides exposure to the full investment process—evaluating opportunities, conducting technical diligence, supporting deal execution, and working with portfolio companies. The ideal candidate holds an MD or PhD and has at least two years of relevant industry experience.

Responsibilities

• Source, evaluate, and recommend investment opportunities in drug development/biopharmaceutical companies, including development and ownership of thematic focus areas.
• Support scientific and clinical due diligence, integrating preclinical data, clinical trial results, regulatory strategy, and market dynamics into investment recommendations.
• Develop and present rigorous investment theses to senior stakeholders, including the global Investment Committee.
• Contribute across the full deal process, coordinating third‑party scientific advisors, KOLs, and commercial consultants.
• Monitor portfolio companies and support the GA team’s capital allocation and value‑creation efforts.
• Leverage clinical and industry networks to generate proprietary deal flow and market intelligence.
• Collaborate with professionals across the firm and foster exceptional knowledge‑sharing.

Qualifications

• MD or PhD in a relevant scientific field (e.g., molecular biology, genetics, biology, chemistry).
• 2–5 years of post‑graduate professional experience, including at least 2 years in the life‑sciences sector (investing, strategy consulting, equity research/investment banking, or biopharma operating role).
• Ability to analyze and integrate data from preclinical and clinical studies, FDA/regulatory correspondence, and market research into investment recommendations.
• Strong foundation in financial modeling with a commitment to deepening analytical expertise.
• Passion for primary scientific literature and active participation in scientific/medical meetings and conferences.
• High familiarity with drug development and regulatory processes.
• Excellent written and verbal communication skills; ability to synthesize and present complex information clearly.
• Professional maturity and presence; comfortable interacting with senior executives and management teams.
• Highly motivated, inquisitive, with a positive, can‑do attitude.
• Ability to take ownership, work independently, manage multiple priorities, and thrive in a fast‑paced, entrepreneurial environment.

Compensation & Benefits

• Base salary of $150,000 – $160,000, with the exact amount determined by role requirements, special skills, and experience.
• Annual discretionary bonuses and long‑term incentive programs for eligible employees.
• Medical insurance, retirement savings contributions, and mental and physical health resources.
• Equal‑pay program and other reward programs supporting a secure, healthy life for employees and their families.